Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin (Q38042744)

27 August 2017

Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin (English)

1 reference

27 August 2017

0 references

1 reference

1 reference

Chandana Mohanty

1

1 reference

27 August 2017

Manasi Das

series ordinal

2

1 reference

27 August 2017

Sanjeeb K Sahoo

series ordinal

3

1 reference

27 August 2017

language of work or name

English

0 references

publication date

13 September 2012

1 reference

Expert Opinion on Drug Delivery

27 August 2017

1 reference

27 August 2017

9

1 reference

27 August 2017

1347-1364

1 reference

27 August 2017

11

1 reference

Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment.

27 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Curcumin: the story so far.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Chemopreventive and therapeutic effects of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Multiple biological activities of curcumin: a short review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Multitargeting by curcumin as revealed by molecular interaction studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

21 January 2018

The targets of curcumin.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Curcumin as chemosensitizer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Dose escalation of a curcuminoid formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Bioavailability of curcumin: problems and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Phase II trial of curcumin in patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

The present and future of nanotechnology in human health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Nanotech approaches to drug delivery and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Receptor mediated tumor targeting: an emerging approach for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Ligand-based targeted therapy for cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Curcumin nanoformulations: a future nanomedicine for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Molecular understanding and modern application of traditional medicines: triumphs and trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Curcumin has bright prospects for the treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Curcumin therapy in inflammatory bowel disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Curcumin modulates free radical quenching in myocardial ischaemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Curcumin and its analogues as potent inhibitors of low density lipoprotein oxidation: H-atom abstraction from the phenolic groups and possible involvement of the 4-hydroxy-3-methoxyphenyl groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Neuroprotective effects of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Folate decorated dual drug loaded nanoparticle: role of curcumin in enhancing therapeutic potential of nutlin-3a by reversing multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Targeted nutlin-3a loaded nanoparticles inhibiting p53-MDM2 interaction: novel strategy for breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Epithelial cell adhesion molecule targeted nutlin-3a loaded immunonanoparticles for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Recent studies on the biofunctions and biotransformations of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Stability of curcumin in buffer solutions and characterization of its degradation products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95CG (Biocurcumax), A Novel Bioenhanced Preparation of Curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Theoretical study on physicochemical properties of curcumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Differential apoptotic and redox regulatory activities of curcumin and its derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Synthesis and exploration of novel curcumin analogues as anti-malarial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Apoptosis-inducing effects of curcumin derivatives in human bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Brain and spinal cord interaction: a dietary curcumin derivative counteracts locomotor and cognitive deficits after brain trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Barrier protective activities of curcumin and its derivative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Curcuminoids, curcumin, and demethoxycurcumin reduce lead-induced memory deficits in male Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Synthesis, cytotoxic and combined cDDP activity of new stable curcumin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Newly synthesized curcumin analog has improved potential to prevent colorectal carcinogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Highly active anticancer curcumin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Cancer nanotechnology: application of nanotechnology in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Pharmacokinetic applicability of a validated liquid chromatography tandem mass spectroscopy method for orally administered curcumin loaded solid lipid nanoparticles to rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Curcumin-artemisinin combination therapy for malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Anti-malarial activities of Andrographis paniculata and Hedyotis corymbosa extracts and their combination with curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Nanosuspensions in drug delivery: recent advances, patent scenarios, and commercialization aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Nanosuspensions in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Preparation and characterization of intravenously injectable curcumin nanosuspension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Bioavailability and delivery of nutraceuticals using nanotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Pharmacokinetics of dietary cancer chemopreventive compound dibenzoylmethane in rats and the impact of nanoemulsion and genetic knockout of Nrf2 on its disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Curcumin-loaded hydrogel nanoparticles: application in anti-malarial therapy and toxicological evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Complexation with phosphatidyl choline as a strategy for absorption enhancement of boswellic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Bioavailability enhancement of curcumin by complexation with phosphatidyl choline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Liposomal drug formulations in cancer therapy: 15 years along the road

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Cyclodextrin-mediated entrapment of curcuminoid 4-[3,5-bis(2-chlorobenzylidene-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Dendrimers bind antioxidant polyphenols and cisplatin drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Synthesis of monofunctional curcumin derivatives, clicked curcumin dimer, and a PAMAM dendrimer curcumin conjugate for therapeutic applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Mucoadhesive curcumin nanospheres: biological activity, adhesion to stomach mucosa and release of curcumin into the circulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Transferrin-conjugated curcumin-loaded superparamagnetic iron oxide nanoparticles induce augmented cellular uptake and apoptosis in K562 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Sustained targeting of Bcr-Abl + leukemia cells by synergistic action of dual drug loaded nanoparticles and its implication for leukemia therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Curcumin-glucoside, A Novel Synthetic Derivative of Curcumin, Inhibits α-Synuclein Oligomer Formation: Relevance to Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

Design, synthesis and evaluation of novel PEGylated curcumin analogs as potent Nrf2 activators in human bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.724676

10.1517/17425247.2012.724676

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference